Comera Life Sciences Holdings, Inc. (CMRA)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: Dec 23, 2024
CMRA Revenue
Comera Life Sciences Holdings had revenue of $136.31K in the quarter ending September 30, 2023, a decrease of -41.98%. This brings the company's revenue in the last twelve months to $1.00M, up 81.79% year-over-year. In the year 2022, Comera Life Sciences Holdings had annual revenue of $633.10K with 97.95% growth.
Revenue (ttm)
1.00M
Revenue Growth
+81.79%
P/S Ratio
0.00
Revenue / Employee
76.95K
Employees
13
Market Cap
6.15K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 633.10K | 313.27K | 97.95% |
Dec 31, 2021 | 319.83K | -123.09K | -27.79% |
Dec 31, 2020 | 442.92K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionComera Life Sciences Holdings News
- 1 year ago - Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option - GlobeNewsWire
- 1 year ago - Comera Life Sciences Announces Process Exploring Strategic Alternatives - GlobeNewsWire
- 1 year ago - Comera Life Sciences Appoints Dorothy Clarke to Board of Directors - GlobeNewsWire
- 1 year ago - Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights - GlobeNewsWire
- 1 year ago - Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference - GlobeNewsWire
- 1 year ago - Comera Life Sciences Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities - GlobeNewsWire
- 1 year ago - Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights - GlobeNewsWire
- 1 year ago - Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform - GlobeNewsWire